About this trial
This study is testing a personalized form of brain stimulation called PrTMS as a treatment for post-traumatic stress disorder (PTSD) in military service members and veterans. Unlike standard approaches, this treatment uses a simple brainwave test (EEG) to tailor the therapy to each individual. Participants will be randomly assigned to receive either active treatment or a comparison (sham) treatment over 6 weeks. Researchers will track changes in PTSD symptoms, mood, sleep, and overall well-being, including using wearable devices to measure things like sleep and heart rate. The goal is to see whether this personalized approach can provide greater and longer-lasting relief for individuals living with PTSD.
Eligibility criteria
Qualifiers
Reserve or former member of the military (veteran status)
Age 18 years or older
Primary diagnosis of post-traumatic stress disorder (PTSD) confirmed by the - Clinician-Administered PTSD Scale for DSM-5 (CAPS-5)
Post-Traumatic Stress Disorder Checklist for DSM-5 (PCL-5) score ≥ 33, indicating clinically significant PTSD symptoms
Disqualifiers
History of open-skull traumatic brain injury
Clinically significant seizure disorder or history of manic episodes
Neurological conditions associated with increased risk (e.g., increased intracranial pressure, brain lesions, stroke, cerebral aneurysm)
Electroencephalogram (EEG) abnormalities suggesting elevated seizure risk
Trial design
Treatments tested in this trial
- Transcranial Magnetic Stimulation
- Transcranial Magnetic Stimulation Sham
Treatment groups
Sponsors and collaborators
Massachusetts General Hospital
Lead sponsor
United States Air Force Research Laboratory
Collaborator